Streetbeat News

Price Targets

KURA

Wedbush analyst Robert Driscoll has maintained an 'Outperform' rating on Kura Oncology (NASDAQ:KURA) but lowered the price target from $40 to $37.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:06 pm

CRTO

Susquehanna analyst Shyam Patil maintains a Neutral rating on Criteo (NASDAQ:CRTO) and lowers the price target from $36 to $26.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:06 pm

BILL

Susquehanna analyst James Friedman maintains a positive outlook on BILL Holdings (NYSE:BILL), but has lowered the price target from $145 to $105.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:04 pm

TPX

Wedbush analyst Seth Basham maintains an Outperform rating on Tempur Sealy Intl (NYSE:TPX) but lowers the price target from $55 to $50.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:04 pm

ABNB

Susquehanna analyst Shyam Patil maintains a positive outlook on Airbnb (NASDAQ:ABNB), but has lowered the price target from $165 to $160.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:02 pm

EPAM

In the last quarter, EPAM Sys (NYSE:EPAM) has received 3 somewhat bullish and 3 indifferent analyst ratings. The average 12-month price target for the company, according to 6 analysts, is $270.33, with a high of $319.00 and a low of $243.00. This average price target has increased by 8.31% over the past month.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 2:00 pm

PCTY

Analysts have provided various ratings for Paylocity Holding (NASDAQ:PCTY) in the last quarter, with 1 bullish, 3 somewhat bullish, and 4 indifferent. Over the past 3 months, 8 analysts have offered 12-month price targets for Paylocity Holding, with an average price target of $218.5, a decrease of 11.54% from the previous average price target of $247.00.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 2:00 pm

RPD

Over the past 3 months, 7 analysts have published their opinion on Rapid7 (NASDAQ:RPD) stock. The company has an average price target of $53.0 with a high of $56.00 and a low of $50.00. This average price target has increased by 11.58% over the past month.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 2:00 pm

ALPN

Wedbush analyst Robert Driscoll maintains an Outperform rating on Alpine Immune Sciences (NASDAQ:ALPN) and raises the price target from $19 to $26.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:59 pm

AAPL

Morgan Stanley analyst Erik Woodring has reiterated an Overweight rating on Apple (NASDAQ:AAPL) and maintained a price target of $210.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:56 pm